2026-2030年全球細胞學市場

全球細胞學市場預計將從 2025 年到 2030 年成長至 24.508 億美元，預測期內複合年成長率為 7.5%。

本報告對全球細胞學市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括癌症和感染疾病率的上升、細胞學和檢查室自動化技術的進步、公眾意識的提高以及大規模篩檢計畫的擴展。

本研究客觀地結合一手和二手訊息，包括主要行業相關人員的意見，進行了這項研究。報告內容包括對主要企業的分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含了歷史數據和預測數據。

本研究指出，數位病理學與人工智慧的融合將是未來幾年全球細胞學市場成長的關鍵促進因素之一。此外，對分子細胞學和輔助檢測的日益重視，以及檢查室自動化和工作流程最佳化技術的不斷普及，預計也將產生顯著的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 混淆因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 2025-2030年市場展望

第5章 市場規模與表現

• 2020-2024年全球細胞學市場
• 2020-2024年最終用戶細分市場分析
• 2020-2024 年方法分析
• 2020-2024年按應用領域分類的細分市場分析
• 2020-2024年區域市場分析
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球細胞生物學市場
• 地緣政治衝突影響全球細胞生物學市場

第7章：五力分析

• 五力模型概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院
• 研究機構和學術機構
• 其他
• 市場機會：依最終用戶分類

第9章 市場區隔：依技術分類

• 比較：按技術
• 液基細胞學
• 常規細胞學
• 市場機會：依技術分類

第10章 市場區隔：依應用

• 比較：透過應用
• 子宮頸癌篩檢
• 除子宮頸癌篩檢外的其他篩檢
• 市場機會：依應用領域分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區
  • 巴西
  • 南非
  • 阿拉伯聯合大公國
  • 土耳其
  • 沙烏地阿拉伯
  • 阿根廷
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Biocare Medical LLC
• CellaVision
• COPAN Diagnostics Inc.
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Hologic Inc.
• IDEXX Laboratories Inc.
• Inpeco SA
• QIAGEN NV
• Sakura Finetek
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare

第16章附錄

The global cytology market is forecasted to grow by USD 2450.8 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global cytology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer and infectious diseases, technological advancements in cytology and laboratory automation, rising awareness and expansion of population-based screening programs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cytology market is segmented as below:

By End-User

• Hospitals
• Research laboratories and academic institutions
• Others

By Technique

• Liquid-based cytology
• Conventional cytology

By Application

• Cervical cancer screening
• Non-cervical cancer screening

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of digital pathology and artificial intelligence as one of the prime reasons driving the global cytology market growth during the next few years. Also, increasing emphasis on molecular cytology and ancillary testing and growing adoption of automation and workflow optimization in laboratories will lead to sizable demand in the market.

The report on the global cytology market covers the following areas:

• Global cytology market sizing
• Global cytology market forecast
• Global cytology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cytology market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Biocare Medical LLC, CellaVision, COPAN Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Hologic Inc., IDEXX Laboratories Inc., Inpeco SA, Koninklijke Philips NV, QIAGEN N.V., Sakura Finetek, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare. Also, the global cytology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technique
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cytology Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cytology Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Technique segment analysis 2020 - 2024
  • Historic Market Size - Technique Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global cytology market
• 6.2 Impact of geopolitical conflicts on global cytology market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2025-2030
• 8.4 Research laboratories and academic institutions - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Technique

• 9.1 Market segments
• 9.2 Comparison by Technique
• 9.3 Liquid-based cytology - Market size and forecast 2025-2030
• 9.4 Conventional cytology - Market size and forecast 2025-2030
• 9.5 Market opportunity by Technique
  • Market opportunity by Technique ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Cervical cancer screening - Market size and forecast 2025-2030
• 10.4 Non-cervical cancer screening - Market size and forecast 2025-2030
• 10.5 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 South Africa - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing prevalence of cancer and infectious diseases
  • Technological advancements in cytology and laboratory automation
  • Rising awareness and expansion of population-based screening programs
• 13.2 Market challenges
  • Acute shortage of skilled cytotechnologists and pathologists
  • Competition from alternative and advanced diagnostic technologies
  • High capital costs and reimbursement hurdles for advanced systems
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of digital pathology and artificial intelligence
  • Increasing emphasis on molecular cytology and ancillary testing
  • Growing adoption of automation and workflow optimization in laboratories

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.6 Biocare Medical LLC
  • Biocare Medical LLC - Overview
  • Biocare Medical LLC - Product / Service
  • Biocare Medical LLC - Key offerings
  • SWOT
• 15.7 CellaVision
  • CellaVision - Overview
  • CellaVision - Product / Service
  • CellaVision - Key offerings
  • SWOT
• 15.8 COPAN Diagnostics Inc.
  • COPAN Diagnostics Inc. - Overview
  • COPAN Diagnostics Inc. - Product / Service
  • COPAN Diagnostics Inc. - Key offerings
  • SWOT
• 15.9 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Business segments
  • Hologic Inc. - Key offerings
  • Hologic Inc. - Segment focus
  • SWOT
• 15.12 IDEXX Laboratories Inc.
  • IDEXX Laboratories Inc. - Overview
  • IDEXX Laboratories Inc. - Business segments
  • IDEXX Laboratories Inc. - Key offerings
  • IDEXX Laboratories Inc. - Segment focus
  • SWOT
• 15.13 Inpeco SA
  • Inpeco SA - Overview
  • Inpeco SA - Product / Service
  • Inpeco SA - Key offerings
  • SWOT
• 15.14 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.15 Sakura Finetek
  • Sakura Finetek - Overview
  • Sakura Finetek - Product / Service
  • Sakura Finetek - Key offerings
  • SWOT
• 15.16 Sysmex Corporation
  • Sysmex Corporation - Overview
  • Sysmex Corporation - Business segments
  • Sysmex Corporation - Key news
  • Sysmex Corporation - Key offerings
  • Sysmex Corporation - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Trivitron Healthcare
  • Trivitron Healthcare - Overview
  • Trivitron Healthcare - Product / Service
  • Trivitron Healthcare - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations